SCHEMBL1534561

SCHEMBL1534561

COc1nccc(C(=O)C#Cc2ccccc2)c1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCP P55072 3/20 0.42
HSP90AA1 P07900 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
AGTR1 P30556 1/20 0.41
PAX8 Q06710 1/20 0.41
TLR9 Q9NR96 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
POLB P06746 1/20 0.40
NLRP3 Q96P20 1/20 0.40
NPSR1 Q6W5P4 3/20 0.39
IKBKB O14920 1/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
OPRK1 P41145 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
APP P05067 1/20 0.35
FFAR1 O14842 1/20 0.34
MITF O75030 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1534490 0.85 VCP (0.41) VCPHSP90AA1NPC1RAB9AAGTR1
SCHEMBL1534392 0.83 TDP1 (0.46) VCPHSP90AA1NPC1RAB9AAGTR1
SCHEMBL1534486 0.76 NPC1 (0.48) VCPNPC1RAB9AMEN1KMT2A
SCHEMBL1534617 0.76 MAPT (0.46) VCPHSP90AA1NPC1RAB9AAGTR1
SCHEMBL16475154 0.76 LMNA (0.47) NPC1RAB9APOLBNPSR1IKBKB
SCHEMBL1534560 0.76 HSP90AA1 (0.46) VCPHSP90AA1NPC1RAB9ANPSR1
SCHEMBL1534679 0.75 VCP (0.44) VCPHSP90AA1NPC1RAB9AAGTR1
SCHEMBL1534467 0.75 NPC1 (0.44) VCPHSP90AA1NPC1RAB9AAGTR1
SCHEMBL1534476 0.74 POLB (0.59) VCPHSP90AA1NPC1RAB9AAGTR1
SCHEMBL1534334 0.73 VCP (0.42) VCPHSP90AA1NPC1RAB9AAGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546376-B2 Pharmaceutical compounds ALMAC DISCOVERY LIMITED (GB) 2013-10-01 US disclosed
US-20120238541-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2012-09-20 US disclosed
EP-2473495-A1 PHARMACEUTICAL COMPOUNDS Almac Discovery Limited (GB) 2012-07-11 EP disclosed
WO-2011033265-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2011-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238541-A1 PHARMACEUTICAL COMPOUNDS PIK3CA, PLK1, MTOR VCP 1895/4885HSP90AA1 1265/4885NPC1 835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.